Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth L Berkow

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Clinical Microbiology Newsletter|March 17, 2025
Antifungal Susceptibility Testing - The Times They Are a Changin'Shawn R Lockhart, Elizabeth L Berkow
Diagnostic Microbiology and Infectious Disease|January 9, 2018
Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida aurisElizabeth L Berkow, Shawn R Lockhart
Clinical Microbiology Newsletter|March 17, 2018
Hot topics in antifungal susceptibility testing: A new drug, a bad bug, sweeping caspofungin testing under the rug, and solving the ECV shrugShawn R Lockhart, Elizabeth L Berkow
Infection and Drug Resistance|August 18, 2017
Fluconazole resistance in <i>Candida</i> species: a current perspectiveElizabeth L Berkow, Shawn R Lockhart
The Journal of Antimicrobial Chemotherapy|August 8, 2018
Activity of novel antifungal compound APX001A against a large collection of Candida aurisElizabeth L Berkow, Shawn R Lockhart
Antimicrobial Agents and Chemotherapy|May 10, 2017
<i>In Vitro</i> Activity of a Novel Glucan Synthase Inhibitor, SCY-078, against Clinical Isolates of Candida aurisElizabeth L Berkow, David Angulo, Shawn R Lockhart
Clinical Microbiology Reviews|May 1, 2020
Antifungal Susceptibility Testing: Current ApproachesElizabeth L Berkow, Shawn R Lockhart, Luis Ostrosky-Zeichner
The Journal of Antimicrobial Chemotherapy|January 6, 2018
Changes in the epidemiological landscape of invasive candidiasisFrederic Lamoth, Shawn R Lockhart, Elizabeth L Berkow, et al.
Journal of Clinical Microbiology|January 7, 2021
Categorizing Susceptibility of Clinical Isolates of <i>Candida auris</i> to Amphotericin B, Caspofungin, and Fluconazole by Use of the CLSI M44-A2 Disk Diffusion MethodNatalie S Nunnally, Tajah Damm, Shawn R Lockhart, et al.
Clinical Microbiology Newsletter|March 6, 2018
<i>Candida auris</i> for the clinical microbiology laboratory: Not your grandfather's <i>Candida</i> speciesShawn R Lockhart, Elizabeth L Berkow, Nancy Chow, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Clinical Microbiology Newsletter|March 17, 2025
Antifungal Susceptibility Testing - The Times They Are a Changin'Shawn R Lockhart, Elizabeth L Berkow
Diagnostic Microbiology and Infectious Disease|January 9, 2018
Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida aurisElizabeth L Berkow, Shawn R Lockhart
Clinical Microbiology Newsletter|March 17, 2018
Hot topics in antifungal susceptibility testing: A new drug, a bad bug, sweeping caspofungin testing under the rug, and solving the ECV shrugShawn R Lockhart, Elizabeth L Berkow
Infection and Drug Resistance|August 18, 2017
Fluconazole resistance in <i>Candida</i> species: a current perspectiveElizabeth L Berkow, Shawn R Lockhart
The Journal of Antimicrobial Chemotherapy|August 8, 2018
Activity of novel antifungal compound APX001A against a large collection of Candida aurisElizabeth L Berkow, Shawn R Lockhart
Antimicrobial Agents and Chemotherapy|May 10, 2017
<i>In Vitro</i> Activity of a Novel Glucan Synthase Inhibitor, SCY-078, against Clinical Isolates of Candida aurisElizabeth L Berkow, David Angulo, Shawn R Lockhart
Clinical Microbiology Reviews|May 1, 2020
Antifungal Susceptibility Testing: Current ApproachesElizabeth L Berkow, Shawn R Lockhart, Luis Ostrosky-Zeichner
The Journal of Antimicrobial Chemotherapy|January 6, 2018
Changes in the epidemiological landscape of invasive candidiasisFrederic Lamoth, Shawn R Lockhart, Elizabeth L Berkow, et al.
Journal of Clinical Microbiology|January 7, 2021
Categorizing Susceptibility of Clinical Isolates of <i>Candida auris</i> to Amphotericin B, Caspofungin, and Fluconazole by Use of the CLSI M44-A2 Disk Diffusion MethodNatalie S Nunnally, Tajah Damm, Shawn R Lockhart, et al.
Clinical Microbiology Newsletter|March 6, 2018
<i>Candida auris</i> for the clinical microbiology laboratory: Not your grandfather's <i>Candida</i> speciesShawn R Lockhart, Elizabeth L Berkow, Nancy Chow, et al.
Pageof 6